757 related articles for article (PubMed ID: 12288679)
1. Contraception in the later reproductive years: a valid aspect of preventive health care.
Speroff L; Sulak PJ
Dialogues Contracept; 1995; 4(5):1-4. PubMed ID: 12288679
[TBL] [Abstract][Full Text] [Related]
2. Choosing a contraceptive. What's best for you?
Anthony J
Am Health; 1994 Apr; 13(3):68-71. PubMed ID: 12290558
[TBL] [Abstract][Full Text] [Related]
3. Weighing risks against benefits in contraceptive safety.
Akhter HH
Draper Fund Rep; 1983 Aug; (12):20-2. PubMed ID: 12338977
[TBL] [Abstract][Full Text] [Related]
4. Reversible contraception for the woman over 35 years of age.
Archer DF
Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
[TBL] [Abstract][Full Text] [Related]
5. [Contraception for women over 40].
Erny R; Mathet M
Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
[TBL] [Abstract][Full Text] [Related]
6. The state of the contraceptive art.
Tyrer LB; Duarte J
Plan Parent Rev; 1983; 3(2):5-7. PubMed ID: 12265618
[TBL] [Abstract][Full Text] [Related]
7. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
8. IUDs, implants, Depo-Provera have "incredible return on investment".
Contracept Technol Update; 1995 Jul; 16(7):81-4. PubMed ID: 12346506
[TBL] [Abstract][Full Text] [Related]
9. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
10. Ask the experts: progestin-only contraceptives.
Hatcher RA; Schnare S
Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
[TBL] [Abstract][Full Text] [Related]
11. Contraception in the perimenopause.
Sparrow M
Curr Ther (Seaforth); 1992 Dec; 33(12):43-8. PubMed ID: 12288572
[TBL] [Abstract][Full Text] [Related]
12. Fertility awareness affects method use.
Barnett B
Netw Res Triangle Park N C; 1996; 17(1):9. PubMed ID: 12320448
[TBL] [Abstract][Full Text] [Related]
13. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
14. [Choosing contraception for adolescents].
Wemeau-jacquemont C
NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
[TBL] [Abstract][Full Text] [Related]
15. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
16. Planned Parenthood continues prescribing birth control for teens.
Contracept Technol Update; 1982 Jul; 3(9):110-2. PubMed ID: 12338301
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives hold top position as leading choice for women.
Contracept Technol Update; 1997 Nov; 18(11):133-6. PubMed ID: 12292767
[TBL] [Abstract][Full Text] [Related]
18. Depo-Provera highly effective as injectable contraceptive.
Denniston GC
Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
[TBL] [Abstract][Full Text] [Related]
19. OCs are currently the second most popular birth control method in U.S.
Contracept Technol Update; 1985 Jan; 6(1):3. PubMed ID: 12279916
[TBL] [Abstract][Full Text] [Related]
20. The myth about contraceptives and breast cancer.
Ibekwe J
Dly Times; 1993 Mar; ():7. PubMed ID: 12179509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
